“ASSESSMENT OF BLOOD MARKERS AFTER RADIONUCLIDE THERAPY FOR OSTEOGENIC METASTASIS OF KIDNEY AND PROSTATE CANCER ”. World Bulletin of Public Health, vol. 12, July 2022, pp. 66-69, https://scholarexpress.net/index.php/wbph/article/view/1135.